Indications For Use
Gel-One Hyaluronate is indicated for the treatment of pain in
osteoarthritis (OA) of the knee in patients who have failed to respond
adequately to non-pharmacologic therapy, non-steroidal
anti-inflammatory drugs (NSAIDs) or simple analgesics, e.g., acetaminophen.
Important Safety Information
Before using Gel-One Hyaluronate, ask your patients if they are
allergic to hyaluronan products, cinnamon, or products from birds such
as feathers, eggs, and poultry. Gel-One Hyaluronate is only for
injection into the knee, performed by a doctor or other qualified
health care professional. Gel-One Hyaluronate injection should not be
used in the presence of a skin disease or infection around the area
where the injection will be given. Gel-One Hyaluronate has not been
tested to show pain relief in joints other than the knee and for
conditions other than OA. Gel-One Hyaluronate has not been tested in
patients who are pregnant, mothers who are nursing, or anyone under
the age of 21. Strenuous or prolonged weight-bearing activities after
treatment are not recommended. The effectiveness of repeat treatment
cycles of Gel-One Hyaluronate has not been established. The side
effects most commonly seen after injection of Gel-One Hyaluronate in
the clinical trial were knee pain, swelling, and/or knee effusion.
These reactions are generally mild and do not last long. For
complete instructions for use, see the package insert.
This material is intended for US Health Care Professionals.
Gel-One is a registered trademark of Seikagaku Corporation.